This bill has been amended

Bill S2058-2013

Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing for use in tissue typing for bone marrow testing

Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens, for utilization in tissue typing for bone marrow testing.

Details

Actions

  • Jan 8, 2014: REFERRED TO INSURANCE
  • Apr 22, 2013: REPORTED AND COMMITTED TO HEALTH
  • Mar 11, 2013: NOTICE OF COMMITTEE CONSIDERATION - REQUESTED
  • Jan 10, 2013: REFERRED TO INSURANCE

Votes

VOTE: COMMITTEE VOTE: - Insurance - Apr 22, 2013
Ayes (8): Carlucci, Breslin, Espaillat, Kennedy, Parker, Stavisky, O'Brien, Peralta
Ayes W/R (3): Martins, Valesky, Young
Nays (8): Seward, Flanagan, Golden, Grisanti, Lanza, Larkin, LaValle, O'Mara

Memo

BILL NUMBER:S2058

TITLE OF BILL: An act to amend the insurance law, in relation to requiring policies and contracts of insurance providing hospital, surgical, or medical care coverage to include coverage for human leukocyte antigen testing

PURPOSE: Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing for use in tissue typing for bone marrow testing.

SUMMARY OF PROVISIONS: Amends the insurance law by adding a new paragraph 30 to subsection (i) of section 3216, adding a new paragraph 19 to subsection (1) of section 3221, and adding a new subsection (ii) to section 4303

EXISTING LAW: This legislation will amend existing law to include this new provision.

JUSTIFICATION: Each year thousands of people require bone marrow transplants to treat diseases such as lymphomas, leukemia's, anemia's, immune deficiency disorders, multiple myeloma and solid tumors. Bone marrow transplants replenish stem cells which are found in greatest concentrations within the bone marrow.

The problem currently faced by patients in need of stem cells is that of finding a proper match of human leukocyte antigens. In order to facilitate the vast number of people who suffer from the life threatening blood disease, a national registry has been set up which records typing of antigens for potential donors. At the present time, bone marrow donors are required to pay a fee up to $75 in order to perform the test and have their name placed on the national donor list. Certainly, people in New York are more likely to be members of the registry if they do not have to pay a fee and if tissue typing is more accessible.

This bill would require health insurance companies to cover the tissue typing fee. The end result would be an increase in the number of bone marrow donors in the registry and a greater likelihood to find possible donor matches.

LEGISLATIVE HISTORY: A.9761 - 1999-2000 A.1186 - 2001-2002 A.777 2003-2004 A.3622 - 2005-2006 A.4084 - 2007-2008 A.4988 - 2009-2010 03/30/11 REFERRED TO INSURANCE 01/04/12 REFERRED TO INSURANCE

FISCAL IMPLICATIONS: None LOCAL FISCAL IMPLICATIONS: None

EFFECTIVE DATE: This act shall take effect on the first of January next succeeding the date on which it shall have become a law and shall apply to all policies and contracts issued, renewed, modified, altered, or amended on or after such date; provided, however, that any rules or regulations necessary for the implementation of this act on its effective date shall be promulgated, and any other means necessary for the implementation of this act on its effective date shall be taken, on or before such effective date.


Text

STATE OF NEW YORK ________________________________________________________________________ 2058 2013-2014 Regular Sessions IN SENATE January 10, 2013 ___________
Introduced by Sen. LATIMER -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT to amend the insurance law, in relation to requiring policies and contracts of insurance providing hospital, surgical, or medical care coverage to include coverage for human leukocyte antigen testing THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 30 to read as follows: (30) EVERY POLICY WHICH PROVIDES HOSPITAL, SURGICAL, OR MEDICAL CARE COVERAGE OR PROVIDES REIMBURSEMENT FOR LABORATORY TESTS OR REIMBURSEMENT FOR DIAGNOSTIC X-RAY SERVICES SHALL PROVIDE COVERAGE FOR HUMAN LEUKOCYTE ANTIGEN TESTING, ALSO REFERRED TO AS HISTOCOMPATIBLE LOCUS ANTIGEN TEST- ING, FOR A, B, AND DR ANTIGENS FOR UTILIZATION IN TISSUE TYPING FOR BONE MARROW TESTING. S 2. Subsection (1) of section 3221 of the insurance law is amended by adding a new paragraph 19 to read as follows: (19) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIVERY IN THIS STATE WHICH PROVIDES HOSPITAL, SURGICAL, OR MEDICAL CARE COVERAGE SHALL PROVIDE COVERAGE FOR HUMAN LEUKOCYTE ANTIGEN TESTING, ALSO REFERRED TO AS HISTOCOMPATIBLE LOCUS ANTIGEN TESTING, FOR A, B, AND DR ANTIGENS FOR UTILIZATION IN TISSUE TYPING FOR BONE MARROW TESTING, EXCEPT THAT THIS PROVISION SHALL NOT APPLY TO A POLICY WHICH COVERS PERSONS EMPLOYED IN MORE THAN ONE STATE OR THE BENEFIT STRUCTURE OF WHICH WAS THE SUBJECT OF COLLECTIVE BARGAINING AFFECTING PERSONS WHO ARE EMPLOYED IN MORE THAN ONE STATE. S 3. Section 4303 of the insurance law is amended by adding a new subsection (jj) to read as follows: (JJ) A MEDICAL EXPENSE INDEMNITY CORPORATION, A HOSPITAL SERVICE CORPORATION OR A HEALTH SERVICE CORPORATION WHICH PROVIDES COVERAGE FOR HOSPITAL, SURGICAL, OR MEDICAL CARE SHALL PROVIDE COVERAGE FOR HUMAN
LEUKOCYTE ANTIGEN TESTING, ALSO REFERRED TO AS HISTOCOMPATIBLE LOCUS ANTIGEN TESTING, FOR A, B, AND DR ANTIGENS FOR UTILIZATION IN TISSUE TYPING FOR BONE MARROW TESTING, EXCEPT THAT THIS PROVISION SHALL NOT APPLY TO A CONTRACT WHICH COVERS PERSONS EMPLOYED IN MORE THAN ONE STATE OR THE BENEFIT STRUCTURE OF WHICH WAS THE SUBJECT OF COLLECTIVE BARGAIN- ING AFFECTING PERSONS WHO ARE EMPLOYED IN MORE THAN ONE STATE. S 4. This act shall take effect on the first of January next succeed- ing the date on which it shall have become a law and shall apply to all policies and contracts issued, renewed, modified, altered, or amended on or after such effective date. Effective immediately any rules or regu- lations necessary for the implementation of this act on its effective date shall be promulgated, and any other measures necessary for the implementation of this act on its effective date shall be taken, on or before such effective date.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Discuss!

blog comments powered by Disqus